富国国证疫苗与生物科技ETF发起式联接A(021280)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
24,538.70 |
14,243.05 |
1,127.01 |
1,287.53 |
| 存出保证金 |
13,850.10 |
6,008.69 |
1,178.27 |
558.16 |
| 交易性金融资产 |
15,583,246.23 |
13,705,920.37 |
9,605,796.27 |
9,336,934.08 |
| 其中:股票投资 |
- |
- |
- |
- |
| 债券投资 |
807,190.74 |
201,440.41 |
304,084.83 |
404,713.12 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
42,888.69 |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
37,353.76 |
54,771.56 |
31,798.95 |
191.88 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
15,683,639.49 |
14,377,015.90 |
9,856,015.17 |
9,466,967.69 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
62,002.79 |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
- |
| 应付赎回款 |
55,684.19 |
113,213.68 |
44,376.81 |
6,405.48 |
| 应付管理人报酬 |
316.60 |
355.78 |
232.75 |
228.04 |
| 应付托管费 |
63.33 |
71.15 |
46.59 |
45.63 |
| 应付销售服务费 |
907.60 |
737.54 |
74.36 |
35.92 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
28.22 |
1.73 |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
19,447.22 |
13,052.87 |
19,447.22 |
13,000.00 |
| 负债合计 |
138,449.95 |
127,432.75 |
64,177.73 |
19,715.07 |
| 所有者权益 |
| 实收基金 |
19,621,704.49 |
15,779,359.16 |
10,955,939.45 |
10,342,361.90 |
| 未分配利润 |
-4,076,514.95 |
-1,529,776.01 |
-1,164,102.01 |
-895,109.28 |
| 所有者权益合计 |
15,545,189.54 |
14,249,583.15 |
9,791,837.44 |
9,447,252.62 |
| 负债及所有者权益总计 |
15,683,639.49 |
14,377,015.90 |
9,856,015.17 |
9,466,967.69 |